Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth Ngure

Showing results (231-240 of 234) with videos related to

Pageof 24
Sort By:
You have reached the last page of results.This site can display upto 234 results.
JCI Insight|November 18, 2025
Genital herpes shedding episodes associate with altered spatial organization and activation of mucosal immune cellsFinn MacLean, Rachael M Zemek, Adino Tesfahun Tsegaye, et al.
The Lancet. HIV|October 28, 2023
Adherence, safety, and choice of the monthly dapivirine vaginal ring or oral emtricitabine plus tenofovir disoproxil fumarate for HIV pre-exposure prophylaxis among African adolescent girls and young women: a randomised, open-label, crossover trialGonasagrie Nair, Connie Celum, Daniel Szydlo, et al.
The Lancet. HIV|February 4, 2021
Safety, uptake, and use of a dapivirine vaginal ring for HIV-1 prevention in African women (HOPE): an open-label, extension studyJared M Baeten, Thesla Palanee-Phillips, Nyaradzo M Mgodi, et al.
The New England Journal of Medicine|July 13, 2012
Antiretroviral prophylaxis for HIV prevention in heterosexual men and womenJared M Baeten, Deborah Donnell, Patrick Ndase, et al.
Pageof 24

Showing results (231-240 of 234) with videos related to

Sort By:
Pageof 24
You have reached the last page of results.This site can display upto 234 results.
JCI Insight|November 18, 2025
Genital herpes shedding episodes associate with altered spatial organization and activation of mucosal immune cellsFinn MacLean, Rachael M Zemek, Adino Tesfahun Tsegaye, et al.
The Lancet. HIV|October 28, 2023
Adherence, safety, and choice of the monthly dapivirine vaginal ring or oral emtricitabine plus tenofovir disoproxil fumarate for HIV pre-exposure prophylaxis among African adolescent girls and young women: a randomised, open-label, crossover trialGonasagrie Nair, Connie Celum, Daniel Szydlo, et al.
The Lancet. HIV|February 4, 2021
Safety, uptake, and use of a dapivirine vaginal ring for HIV-1 prevention in African women (HOPE): an open-label, extension studyJared M Baeten, Thesla Palanee-Phillips, Nyaradzo M Mgodi, et al.
The New England Journal of Medicine|July 13, 2012
Antiretroviral prophylaxis for HIV prevention in heterosexual men and womenJared M Baeten, Deborah Donnell, Patrick Ndase, et al.
Pageof 24